![GP100080: MUC1(126-149)-Tn(130,131,144) Pack Size:1 mg 2-[4-(β-D-Glucopyranuronosyloxy)phenyl]-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-6-yl β-D-Glucopyranosiduronic Acid](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/ser-agalnac-R_15ea1186-083d-4088-8a72-af6bb15f891f.svg?v=1732815768)
Pay in 4 interest-free payments of $59.38 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
2-[4-(β-D-Glucopyranuronosyloxy)phenyl]-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-6-yl β-D-Glucopyranosiduronic Acid
mimicking the inner N-glycan substructure released by endo-β-mannosidase activity
4)-tri-O-acetyl-β-D-glucopyranosyl)-L-threonine
3-Aminopropyl (Neu5Acα2-6Gal β1-4GlcNAc)
This compound provides an α-anomeric galactose building block for glycoconjugate synthesis
GP100080: MUC1(126-149)-Tn(130,131,144) Pack Size:1 mg 2-[4-(β-D-Glucopyranuronosyloxy)phenyl]-3-[4-[2-(1-piperidinyl)ethoxy]benzoyl]benzo[b]thien-6-yl β-D-Glucopyranosiduronic AcidC119H188N32O47 2818. 95 MUC1 (UniProt ID P15941) synthetic glycopeptide fragment (Pro126 Gly149; UniProt position 126 149, aa length 24) from the tandem repeat (TR) region of the MUC1 protein. The fragment contains tumor associated carbohydrate antigen (TACA), Tn antigen, O glycosylation ( GalNAc) at Ser130, Thr131 and Thr144. The C terminus is carboxylic acid. MUC1(126 149) Tn(130,131,144) Mucin1; Synthetic MUC 1 (tri Tn) glycopeptide
